Eltrombopag in Good's Syndrome

Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good&...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristiansen, Håvard Anton, Spetalen, Signe, Fløisand, Yngvar, Heldal, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217369/
https://www.ncbi.nlm.nih.gov/pubmed/25389501
http://dx.doi.org/10.1155/2014/172139
_version_ 1782342390257811456
author Kristiansen, Håvard Anton
Spetalen, Signe
Fløisand, Yngvar
Heldal, Dag
author_facet Kristiansen, Håvard Anton
Spetalen, Signe
Fløisand, Yngvar
Heldal, Dag
author_sort Kristiansen, Håvard Anton
collection PubMed
description Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good's syndrome with immune-mediated T-cell driven pancytopenia and absence of megakaryopoiesis. He was successfully treated with eltrombopag resulting in a multilineage clinical response.
format Online
Article
Text
id pubmed-4217369
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42173692014-11-11 Eltrombopag in Good's Syndrome Kristiansen, Håvard Anton Spetalen, Signe Fløisand, Yngvar Heldal, Dag Case Rep Hematol Case Report Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good's syndrome with immune-mediated T-cell driven pancytopenia and absence of megakaryopoiesis. He was successfully treated with eltrombopag resulting in a multilineage clinical response. Hindawi Publishing Corporation 2014 2014-10-19 /pmc/articles/PMC4217369/ /pubmed/25389501 http://dx.doi.org/10.1155/2014/172139 Text en Copyright © 2014 Håvard Anton Kristiansen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kristiansen, Håvard Anton
Spetalen, Signe
Fløisand, Yngvar
Heldal, Dag
Eltrombopag in Good's Syndrome
title Eltrombopag in Good's Syndrome
title_full Eltrombopag in Good's Syndrome
title_fullStr Eltrombopag in Good's Syndrome
title_full_unstemmed Eltrombopag in Good's Syndrome
title_short Eltrombopag in Good's Syndrome
title_sort eltrombopag in good's syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217369/
https://www.ncbi.nlm.nih.gov/pubmed/25389501
http://dx.doi.org/10.1155/2014/172139
work_keys_str_mv AT kristiansenhavardanton eltrombopagingoodssyndrome
AT spetalensigne eltrombopagingoodssyndrome
AT fløisandyngvar eltrombopagingoodssyndrome
AT heldaldag eltrombopagingoodssyndrome

Ejemplares similares